Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12205109rdf:typepubmed:Citationlld:pubmed
pubmed-article:12205109lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:12205109lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:12205109lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:12205109lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:12205109lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:12205109lifeskim:mentionsumls-concept:C1852989lld:lifeskim
pubmed-article:12205109lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12205109lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12205109pubmed:issue9lld:pubmed
pubmed-article:12205109pubmed:dateCreated2002-9-2lld:pubmed
pubmed-article:12205109pubmed:abstractTextA large family with dominantly inherited rhegmatogenous retinal detachment, premature arthropathy, and development of phalangeal epiphyseal dysplasia, resulting in brachydactyly was linked to COL2A1, the gene encoding proalpha1(II) collagen. Mutational analysis of the gene by exon sequencing identified a novel mutation in the C-propeptide region of the molecule. The glycine to aspartic acid change occurred in a region that is highly conserved in all fibrillar collagen molecules. The resulting phenotype does not fit easily into pre-existing subgroups of the type II collagenopathies, which includes spondyloepiphyseal dysplasia, and the Kniest, Strudwick, and Stickler dysplasias.lld:pubmed
pubmed-article:12205109pubmed:languageenglld:pubmed
pubmed-article:12205109pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12205109pubmed:citationSubsetIMlld:pubmed
pubmed-article:12205109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12205109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12205109pubmed:statusMEDLINElld:pubmed
pubmed-article:12205109pubmed:monthSeplld:pubmed
pubmed-article:12205109pubmed:issn1468-6244lld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:TysonJJlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:NIWACClld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:WilliamsNNlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:MorganJJlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:RichardsA JAJlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:PopeF MFMlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:HughesHHlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:SneadM PMPlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:PickeringEElld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:HolmansPPlld:pubmed
pubmed-article:12205109pubmed:authorpubmed-author:BearcroftP...lld:pubmed
pubmed-article:12205109pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12205109pubmed:volume39lld:pubmed
pubmed-article:12205109pubmed:ownerNLMlld:pubmed
pubmed-article:12205109pubmed:authorsCompleteYlld:pubmed
pubmed-article:12205109pubmed:pagination661-5lld:pubmed
pubmed-article:12205109pubmed:dateRevised2008-11-20lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:meshHeadingpubmed-meshheading:12205109...lld:pubmed
pubmed-article:12205109pubmed:year2002lld:pubmed
pubmed-article:12205109pubmed:articleTitleVitreoretinopathy with phalangeal epiphyseal dysplasia, a type II collagenopathy resulting from a novel mutation in the C-propeptide region of the molecule.lld:pubmed
pubmed-article:12205109pubmed:affiliationDepartment of Pathology, University of Cambridge, Cambridge, UK. arichard@hgmp.mrc.ac.uklld:pubmed
pubmed-article:12205109pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12205109pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:12205109pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1280entrezgene:pubmedpubmed-article:12205109lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12205109lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12205109lld:pubmed